|
|
Ichiro Shiojima, Kaori Sato, Yasuhiro Izumiya, Stephan Schiekofer, Masahiro Ito, Ronglih Liao, Wilson S. Colucci, Kenneth Walsh
J Clin Invest. 2005;
115(8):2108
doi:10.1172/JCI24682
Abstract |
Full text
| PDF

A
lthough increased external load initially induces cardiac hypertrophy with preserved contractility, sustained overload eventually leads to heart failure through poorly understood mechanisms. Here we describe a conditional transgenic system in mice characterized by the sequential development of adaptive cardiac hypertrophy with preserved contractility in the acute phase and dilated cardiomyopathy in the chronic phase following the induction of an activated Akt1 gene in the heart. Coronary angiogenesis was enhanced during the acute phase of adaptive cardiac growth but reduced as hearts underwent pathological remodeling. Enhanced angiogenesis in the acute phase was associated with mammalian target of rapamycin–dependent induction of myocardial VEGF and angiopoietin-2 expression. Inhibition of angiogenesis by a decoy VEGF receptor in the acute phase led to decreased capillary density, contractile dysfunction, and impaired cardiac growth. Thus, both heart size and cardiac function are angiogenesis dependent, and disruption of coordinated tissue growth and angiogenesis in the heart contributes to the progression from adaptive cardiac hypertrophy to heart failure.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(118)
| Title and authors |
Publication |
Year |
Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines
Sebastian Szmit, Przemysław Langiewicz, Jakub Żłnierek, Paweł Nurzyński, Magdalena Zaborowska, Krzysztof J. Filipiak, Grzegorz Opolski, Cezary Szczylik
|
Kidney Blood Press Res
|
2012 |
S6K inhibition renders cardiac protection against myocardial infarction through PDK1 phosphorylation of Akt
Ruomin Di, Xiangqi Wu, Zai Chang, Xia Zhao, Qiuting Feng, Shuangshuang Lu, Qing Luan, Brian A. Hemmings, Xinli Li, Zhongzhou Yang
|
Biochem. J.
|
2012 |
Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
Dao-Fu Dai, Tony Chen, Simon Johnson, Hazel H. Szeto, Peter S. Rabinovitch
|
Antioxidant Redox Signal
|
2012 |
Phosphorylation of basic helix–loop–helix transcription factor Twist in development and disease
Gongda Xue, Brian A. Hemmings
|
Biochem. Soc. Trans.
|
2012 |
Cellular plasticity: the good, the bad, and the ugly? Microenvironmental influences on progenitor cell therapy
Jan-Renier A.J. Moonen, Martin C. Harmsen, Guido Krenning
|
Can. J. Physiol. Pharmacol.
|
2012 |
Multimarker approach for heart failure management: Perspectives and limitations
Daniela Giannessi
|
Pharmacological Research
|
2011 |
MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes
Jianhu Zhang, Vishnu Chintalgattu, Tiffany Shih, Di Ai, Ying Xia, Aarif Y. Khakoo
|
Journal of Molecular and Cellular Cardiology
|
2011 |
Redox signaling in cardiac myocytes
Celio X.C. Santos, Narayana Anilkumar, Min Zhang, Alison C. Brewer, Ajay M. Shah
|
Free Radical Biology and Medicine
|
2011 |
Autophagy in Cardiac Plasticity and Disease
Joseph A. Hill
|
Pediatr Cardiol
|
2011 |
Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy
E. D. Abel, T. Doenst
|
Cardiovascular Research
|
2011 |
|